Link to this page
Medical Subject Headings
| Preferred Name | Oxyphenbutazone | |
| Synonyms |
Diflamil Hydroxyphenylbutazone 3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl- Oxyphenylbutazone Tanderil |
|
| Definitions |
A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27) |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D010113 |
|
| altLabel |
Diflamil Hydroxyphenylbutazone 3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl- Oxyphenylbutazone Tanderil
|
|
| AN |
a non-steroidal anti-inflamm agent
|
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
| cui |
C1563800 C1578181 C0030078
|
|
| DC |
1
|
|
| definition |
A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
|
|
| DX |
19640101
|
|
| HN |
64(63)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
H806S4B3NS 0
|
|
| isa | ||
| LT |
TRD
|
|
| Machine permutation |
64
|
|
| Mapped from |
http://purl.bioontology.org/ontology/MESH/C030771 |
|
| MDA |
19990101
|
|
| MMR |
20170524
|
|
| MN |
D03.383.129.539.850.777.700
|
|
| notation |
D010113
|
|
| PA |
D000894
|
|
| prefLabel |
Oxyphenbutazone
|
|
| RR |
129-20-4 (Oxyphenbutazone)
|
|
| TERMUI |
T029913 T029912 T613153 T029911 T613151
|
|
| TH |
UK FDA SRS (2014) ES UNK (19XX) USP (19XX)
|
|
| tui |
T109 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |